 Aminophylline
"Aminophylline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.
| Descriptor ID |
D000628
|
| MeSH Number(s) |
D02.092.782.258.368.050 D03.438.759.758.824.751.075
|
| Concept/Terms |
Aminophylline- Aminophylline
- Theophyllamine
- Theophylline Ethylenediamine
- Ethylenediamine, Theophylline
Aminodur- Aminodur
- Key Brand of Aminophylline
- Berlex Brand of Aminophylline
Aminophyllin- Aminophyllin
- Searle Brand of Aminophylline
- OPW Brand of Aminophylline
Aminophylline DF- Aminophylline DF
- Interstate Drug Exchange Brand of Aminophylline
- Schein Brand of Aminophylline
- Roxanne Brand of Aminophylline
- Rugby Brand of Aminophylline
- Barre Brand of Aminophylline
- Major Brand of Aminophylline
Clonofilin- Clonofilin
- Clonmel Brand of Aminophylline
Corophyllin- Corophyllin
- SmithKline Beecham Brand of Aminophylline
Drafilyn- Drafilyn
- Zafiro Brand of Aminophylline
Duraphyllin- Duraphyllin
- Durachemie Brand of Aminophylline
Eufilina- Eufilina
- Euphyllin
- Byk Brand of Aminophylline
Godafilin- Godafilin
- Merck Brand of Aminophylline
Mini-Lix- Mini-Lix
- Ferndale Brand of Aminophylline
Phyllocontin- Phyllocontin
- Purdue Frederick Brand of Aminophylline
- Napp Brand of Aminophylline
Phyllotemp- Phyllotemp
- Mundiphyllin
- Mundipharma Brand of Aminophylline
Tari-Dog- Tari-Dog
- TVM Brand of Aminophylline
Theophyllin EDA-ratiopharm- Theophyllin EDA-ratiopharm
- Theophyllin EDA ratiopharm
- Theophyllin EDAratiopharm
- ratiopharm Brand of Aminophylline
Truphylline- Truphylline
- G & W Brand of Aminophylline
- United Research Brand of Aminophylline
Afonilum- Afonilum
- Knoll Brand of Aminophylline
- Carine
|
Below are MeSH descriptors whose meaning is more general than "Aminophylline".
Below are MeSH descriptors whose meaning is more specific than "Aminophylline".
This graph shows the total number of publications written about "Aminophylline" by people in this website by year, and whether "Aminophylline" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2017 | 0 | 1 | 1 | | 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminophylline" by people in Profiles.
-
Abidov A, Dilsizian V, Doukky R, Duvall WL, Dyke C, Elliott MD, Hage FG, Henzlova MJ, Johnson NP, Schwartz RG, Thomas GS, Einstein AJ. Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR. J Nucl Cardiol. 2019 Jun; 26(3):1007-1014.
-
Abidov A, Dilsizian V, Doukky R, Duvall WL, Dyke C, Elliott MD, Hage FG, Henzlova MJ, Johnson NP, Schwartz RG, Thomas GS, Einstein AJ. Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR. J Cardiovasc Magn Reson. 2018 12 20; 20(1):87.
-
Vij A, Golzar Y, Doukky R. Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
-
Fughhi I, Campagnoli T, Ali A, Doukky R. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging. J Nucl Cardiol. 2017 10; 24(5):1571-1578.
-
Rangel MO, Morales Demori R, Voll ST, Wassouf M, Dick R, Doukky R. Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
-
Ballany W, Mansour K, Morales Demori R, Al-Amoodi M, Doukky R. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
-
Rangel MO, Demori RM, Doukky R. Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Am J Ther. 2013 Nov-Dec; 20(6):622-9.
-
Doukky R, Rangel MO, Dick R, Wassouf M, Alqaid A, Margeta B. Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
-
Doukky R, Morales Demori R, Jain S, Kiriakos R, Mwansa V, Calvin JE. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|